KMC Speciality Hospitals (India) Ltd
524520KMC Speciality Hospitals (India) Ltd's earnings have outrun its stock. EPS grew +119.1% in a year against a +106.5% price move.
Biggest watch item: margins are the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on margins holding.
The price is in a confirmed uptrend (35 weeks in) while the P/E sits at the 57th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +200.0% year on year, and 179% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
KMC Speciality Hospitals (India) Ltd trades at ₹135, in a confirmed uptrend and 35 weeks into that stage. That is +43.6% against its own 200-day average. It sits at 92% of a 52-week range of ₹66 to ₹141. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 50 straight weeks.
Today the stock is in a confirmed uptrend — week 35 of stage 2, confirmed. At ₹135 it trades +43.6% versus its 200-day average and sits at 92% of its 52-week range (₹66–₹141).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +1,715% while the NIFTY 500 moved +280% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 50 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
→ The trend is one thing; the bill is another. Are you paying up for it? Next: the P/E sits at the 57th percentile of its own range.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
KMC Speciality Hospitals (India) Ltd trades at 45.0× P/E, mid-range by its own standards (57th percentile). Its long-run median P/E is 43.0×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 45.0× is mid-range by its own standards (57th percentile), against a long-run median of 43.0× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +119.1% against a +106.5% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the +27.7%/yr price move, ~+29.8%/yr came from earnings growth and ~−2.1 pp from the multiple (compressing); over 10y, of the +33.4%/yr price move, ~+29.3%/yr came from earnings growth and ~+4.1 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
KMC Speciality Hospitals (India) Ltd reads as turning around on its fundamental arc. Turning around — profit growth swung from −16.7% at the trough to +108.7%, a 4-quarter improving streak, ROCE holding at 26.0%. The read is built from 8 quarters across 4 curves, on partial evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +31.9% | +25.2% | +24.3% | +21.7% |
| Profit | +123.8% | +20.3% | +29.3% | +31.7% |
| EPS | +119.1% | +20.5% | +29.8% | +30.5% |
| Share price | +106.5% | +19.2% | +27.7% | +33.4% |
→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.
4-Factor Sector Score
80.2/100 — rank 1 of 19 in Hospitals · 79% evidence confidence
KMC Speciality Hospitals (India) Ltd scores 80.2 out of 100 against the 19 companies it is compared with in Hospitals, ranking 1. Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
The four contributions add to the total exactly: 30.8 + 18.9 + 11 + 19.5 = 80.2. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
KMC Speciality Hospitals (India) Ltd reported ₹82.0 Cr of revenue in the Mar 26 quarter, +34.4% year on year. That is the 11th straight quarter of year-on-year growth. Over 10 years it has compounded at 21.7% a year. The last full year, FY26, came in at ₹306 Cr. The last four reported quarters add to ₹306 Cr.
KMC Speciality Hospitals (India) Ltd reported ₹82.0 Cr of revenue in the Mar 26 quarter, +34.4% year on year. That is the 11th straight quarter of year-on-year growth. Over 10 years it has compounded at 21.7% a year. The last full year, FY26, came in at ₹306 Cr. The last four reported quarters add to ₹306 Cr.
FY26 revenue came in at ₹306 Cr (+31.9% on the year), capping 10 years at 21.7% compound. The latest quarter (Mar 26) printed ₹82.0 Cr, +34.4% year on year — the 11th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +32.3% growth against the decade's 21.7% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +32.5% over the last 4 quarters against +31.5%/yr over the last 8 — stabilising; TTM profit +108.7% vs +26.5%/yr — accelerating.
→ Revenue grew — did margins hold as it scaled? Next: 31.0% this quarter (+6.0 pp YoY).
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
KMC Speciality Hospitals (India) Ltd's operating margin is 31.0% in the Mar 26 quarter, +6.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 13 fiscal years the operating margin has ranged 5.0% to 29.0%.
KMC Speciality Hospitals (India) Ltd's operating margin is 31.0% in the Mar 26 quarter, +6.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 13 fiscal years the operating margin has ranged 5.0% to 29.0%.
The latest quarter's operating margin is 31.0%, +6.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 5.0%–29.0%, and FY26's 29.0% is the top of that band — a record year.
Why the margin moved: operating margin went +6.2 pp year on year while gross margin went +0.8 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
→ Margins held — did that reach the bottom line? Next: profit +200.0% in the latest quarter.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
KMC Speciality Hospitals (India) Ltd earned ₹15.0 Cr of net profit in the Mar 26 quarter, +200.0% year on year. It is the 4th consecutive quarter of growth. Full-year FY26 profit was ₹47.0 Cr. The 10-year compound rate is 31.7%. That is 18.3% of the quarter's revenue. The same quarter a year earlier earned ₹5.0 Cr.
KMC Speciality Hospitals (India) Ltd earned ₹15.0 Cr of net profit in the Mar 26 quarter, +200.0% year on year. It is the 4th consecutive quarter of growth. Full-year FY26 profit was ₹47.0 Cr. The 10-year compound rate is 31.7%. That is 18.3% of the quarter's revenue. The same quarter a year earlier earned ₹5.0 Cr.
Mar 26 profit was ₹15.0 Cr, +200.0% year on year — the 4th consecutive quarter of growth. On the full year, FY26 printed ₹47.0 Cr (+123.8%), and the 10-year compound rate is 31.7%.
Why profit moved: revenue contributed +34.4% and the margin +6.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +120.8% vs revenue +32.3%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
→ Profit rose — but did the cash follow? Next: 179% of the last 3 years' profit arrived as cash.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 179% of KMC Speciality Hospitals (India) Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹79.0 Cr of operating cash against ₹47.0 Cr of profit. After ₹22.0 Cr of capital spending, ₹57.0 Cr was left as free cash.
FY26: operating cash of ₹79.0 Cr against reported profit of ₹47.0 Cr, leaving free cash of ₹57.0 Cr after ₹22.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 179% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 179%: the cash cycle stretched 26 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: the bigger cash user is investment — capital spending ran 3.6× depreciation over three years, so the next section's job is to check what that build-out is buying.
→ So follow the cash to where it goes. Next: ₹180 Cr of building over 3 years.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
KMC Speciality Hospitals (India) Ltd's cash conversion cycle runs −42 days in FY26, up from −68 days in FY21. Capital spending ran ₹180 Cr over the last 3 years. At FY26 sales of ₹306 Cr each day of that cycle holds about ₹0.8 Cr, so roughly ₹−35.0 Cr sits inside the business at any moment.
FY26: debtors at 9 days, inventory at 31 days — roughly 1.0 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of −42 days, looser than FY21's −68.
The full loop: cash goes out to suppliers and production on day 0; stock waits 31 days to sell; customers pay about 9 days after that; and suppliers themselves are paid at 82 days — netting out to the −42-day cycle.
In money terms: at FY26 sales of ₹306 Cr, each day of the cycle holds about ₹0.8 Cr — so the −42-day loop keeps roughly ₹−35.0 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹180 Cr over the last 3 fiscal years against ₹50.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
→ Does all this activity actually earn its cost of capital? Next: ROCE is 26%.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
KMC Speciality Hospitals (India) Ltd earns a ROCE of 26% in FY26. That is up from a trough of 2% in FY14. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 15.4% net margin on 0.92× asset turns.
FY26 ROCE is 26%, recovered from a FY14 trough of 2% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 15.4% net margin × 0.92× asset turns × 1.58× balance-sheet leverage ≈ 22.4% on equity. Margin is doing the heavy lifting; leverage is modest — this is an earned return, not a borrowed one.
→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.40.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
KMC Speciality Hospitals (India) Ltd carries ₹84.0 Cr of borrowings against ₹210 Cr of equity in FY26, a debt-to-equity of 0.40. Operating profit covers the interest bill 11×. Over 5 years borrowings went from ₹29.0 Cr to ₹84.0 Cr. Capital spending ran ₹180 Cr across the last 3 of those years.
FY26: borrowings of ₹84.0 Cr against equity of ₹210 Cr — a debt-to-equity of 0.40. Operating profit covers the interest bill 11×. Over 5 years borrowings went from ₹29.0 Cr to ₹84.0 Cr while capital spending ran ₹180 Cr in just the last 3 — part of the build-out is riding on borrowed money.
→ Who owns this, and are they adding or leaving? Next: the register is quiet.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of KMC Speciality Hospitals (India) Ltd moved a full percentage point over the last two years — the register is quiet. Foreign institutions moved +0.0 points over the same window, to 0.0%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: +0.0 points over 8 quarters to 75.0%; Foreign institutions: +0.0 points over 8 quarters to 0.0%.
→ One last check: does the safety math agree? Next: the balance-sheet safety line.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
KMC Speciality Hospitals (India) Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | P/E | Mkt cap | Revenue | EPS | ROCE | Stage |
|---|---|---|---|---|---|---|
| KMC Speciality Hospitals (India) Ltd this page | 45.0× | ₹2,102 Cr | Turning around | |||
| Apollo Hospitals Enterprise Ltd | 64.7× | ₹1.3L Cr | Consistent | |||
| Max Healthcare Institute Ltd | 70.9× | ₹1.1L Cr | Topping out | |||
| Fortis Healthcare Ltd | 67.8× | ₹71,623 Cr | Mixed | |||
| Aster DM Healthcare Ltd | 168.0× | ₹68,483 Cr | No read | |||
| Narayana Hrudayalaya Ltd | 47.1× | ₹40,085 Cr | Turning around | |||
| Global Health Ltd | 66.2× | ₹36,862 Cr | Consistent | |||
| Krishna Institute of Medical Sciences Ltd | 135.0× | ₹33,510 Cr | Mixed | |||
| Rainbow Childrens Medicare Ltd | 59.8× | ₹14,806 Cr | Mixed | |||
| Jupiter Life Line Hospitals Ltd | 55.9× | ₹10,595 Cr | Mixed | |||
| Healthcare Global Enterprises Ltd | 346.0× | ₹9,952 Cr | Mixed | |||
| Yatharth Hospital & Trauma Care Services Ltd | 46.1× | ₹8,082 Cr | Mixed | |||
| Kovai Medical Center & Hospital Ltd | 26.2× | ₹6,394 Cr | Consistent | |||
| Artemis Medicare Services Ltd | 41.2× | ₹4,365 Cr | Consistent | |||
| Indraprastha Medical Corporation Ltd | 18.2× | ₹3,342 Cr | Mixed | |||
| Dr Agarwals Eye Hospital Ltd | 34.6× | ₹2,427 Cr | Mixed | |||
| Sakar Healthcare Ltd | 49.5× | ₹1,785 Cr | Improving | |||
| Shalby Ltd | 47.1× | ₹1,762 Cr | Turning around | |||
| KMC Speciality Hospitals (India) Ltd | 37.0× | ₹1,354 Cr | Turning around | |||
| GPT Healthcare Ltd | 30.4× | ₹1,310 Cr | Turning around |
Frequently asked questions
What is KMC Speciality Hospitals (India) Ltd's share price today?
KMC Speciality Hospitals (India) Ltd trades at ₹135, +106.5% over the past year. The company is valued at ₹2,102 Cr. The stock sits at 92% of its 52-week range of ₹66–₹141, +43.6% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 35 weeks in. — as of 24 July 2026.
What were KMC Speciality Hospitals (India) Ltd's latest quarterly results?
KMC Speciality Hospitals (India) Ltd reported revenue of ₹82.0 Cr and net profit of ₹15.0 Cr for the Mar 26 quarter. Revenue rose 34.4% and profit rose 200.0% year on year. Earnings per share were ₹0.90. The operating margin was 31.0%, 6.0 pp higher than a year earlier. — as of 24 July 2026.
What is KMC Speciality Hospitals (India) Ltd's revenue?
KMC Speciality Hospitals (India) Ltd reported revenue of ₹82.0 Cr in the Mar 26 quarter, +34.4% year on year. For the full FY26 fiscal year, revenue was ₹306 Cr (+31.9%). Over the last 10 years revenue compounded at 21.7% a year. — as of 24 July 2026.
What is KMC Speciality Hospitals (India) Ltd's profit?
KMC Speciality Hospitals (India) Ltd earned ₹15.0 Cr of net profit in the Mar 26 quarter, +200.0% year on year — the 4th straight quarter of growth. Full-year FY26 profit was ₹47.0 Cr. The operating margin ran 31.0% in the latest quarter. — as of 24 July 2026.
What is KMC Speciality Hospitals (India) Ltd's market cap?
KMC Speciality Hospitals (India) Ltd's market capitalisation is ₹2,102 Cr at a share price of ₹135. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 24 July 2026.
What is KMC Speciality Hospitals (India) Ltd's P/E ratio?
KMC Speciality Hospitals (India) Ltd trades at a P/E of 45.0×, at the 57th percentile of its own 10-year range, against a long-run median of 43.0×. This is a comparison with the stock's own history, not a value call — as of 24 July 2026.
Does KMC Speciality Hospitals (India) Ltd pay a dividend?
No — KMC Speciality Hospitals (India) Ltd has recorded a dividend payout of 0% of profit in each of its last 13 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 24 July 2026.
Is KMC Speciality Hospitals (India) Ltd overvalued?
On its own history, KMC Speciality Hospitals (India) Ltd looks mid-range against its own history: its P/E of 45.0× sits at the 57th percentile of its 10-year range (long-run median 43.0×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 24 July 2026.
Is KMC Speciality Hospitals (India) Ltd growing?
Yes — KMC Speciality Hospitals (India) Ltd is growing: latest-quarter revenue +34.4% year on year, profit +200.0%, and the margin +6.0 pp at 31.0%. The 10-year compound rates are 21.7% (revenue) and 31.7% (profit). The earnings engine currently reads: improving — as of 24 July 2026.
How is KMC Speciality Hospitals (India) Ltd performing?
KMC Speciality Hospitals (India) Ltd is in a confirmed uptrend, 35 weeks in. Its latest quarter's revenue rose 34.4% and profit rose 200.0% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 50 weeks. This describes what the data did, not a rating. — as of 24 July 2026.
What stage is KMC Speciality Hospitals (India) Ltd in?
Turning around — profit growth swung from −16.7% at the trough to +108.7%, a 4-quarter improving streak, ROCE holding at 26.0%. The read comes from the last 12 quarters of growth (revenue growth +32.5% latest, profit growth +108.7% latest, eps growth +116.7% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 24 July 2026.
Is KMC Speciality Hospitals (India) Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 35 of stage 2), trading +43.6% versus its 200-day average and at 92% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 24 July 2026.
Is KMC Speciality Hospitals (India) Ltd beating the market?
On recent form, yes — KMC Speciality Hospitals (India) Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 50 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +1,715% against the NIFTY 500's +280% — ahead of the index over the full window. — as of 24 July 2026.
Will KMC Speciality Hospitals (India) Ltd's share price go up?
This page publishes no price forecast for KMC Speciality Hospitals (India) Ltd. What it measures instead: the share price is ₹135, the price is in a confirmed uptrend 35 weeks in. Its P/E of 45.0× sits at the 57th percentile of its own 10-year range. — as of 24 July 2026.
Who owns KMC Speciality Hospitals (India) Ltd?
Promoters hold 75.0% of KMC Speciality Hospitals (India) Ltd, foreign institutions 0.0%, domestic institutions null% and the public 25.0% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 24 July 2026.
Does KMC Speciality Hospitals (India) Ltd have too much debt?
It is moderate — KMC Speciality Hospitals (India) Ltd's debt-to-equity is 0.40, and operating profit covers the interest bill 11×. FY26 borrowings were ₹84.0 Cr against equity of ₹210 Cr. Read the returns on this page with that leverage in mind — as of 24 July 2026.
What is KMC Speciality Hospitals (India) Ltd's capex?
KMC Speciality Hospitals (India) Ltd spent ₹180 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹22.0 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 24 July 2026.
What is KMC Speciality Hospitals (India) Ltd's cash flow?
KMC Speciality Hospitals (India) Ltd generated ₹79.0 Cr of operating cash flow in FY26 and ₹57.0 Cr of free cash flow after ₹22.0 Cr of capital spending. Reported profit that year was ₹47.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 24 July 2026.
Is KMC Speciality Hospitals (India) Ltd's profit real cash?
Yes — over the last 3 fiscal years, 179% of KMC Speciality Hospitals (India) Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹79.0 Cr against reported profit of ₹47.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 24 July 2026.
Where is KMC Speciality Hospitals (India) Ltd in its business cycle?
KMC Speciality Hospitals (India) Ltd's FY26 operating margin was 29.0%, against a 13-year band of 5.0%–29.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 31.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 24 July 2026.
What could break the KMC Speciality Hospitals (India) Ltd story?
Biggest watch item: margins are the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on margins holding. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 24 July 2026.
Is KMC Speciality Hospitals (India) Ltd a stock worth studying right now?
This is not investment advice. The machine read: KMC Speciality Hospitals (India) Ltd's earnings have outrun its stock. EPS grew +119.1% in a year against a +106.5% price move. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 24 July 2026.